Drug Type Therapeutic vaccine, Immune cell therapy |
Synonyms GVAX Pancreas(Aduro Biotech), Panc 10.05/Panc 6.03(Aduro Biotech) |
Target- |
Mechanism Immunostimulants |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Pancreatic Adenocarcinoma | Phase 2 | US | 18 Jul 2016 | |
Adenocarcinoma | Phase 2 | US | 02 Jan 2015 | |
Pancreatic adenocarcinoma metastatic | Phase 2 | US | 21 Sep 2011 | |
Secondary malignant neoplasm of pancreas | Phase 2 | US | 21 Sep 2011 |
Phase 2 | 61 | imbuawvorm(lmmnqvpmbl) = qwmxdzgrxa iyvztwedqq (qixkfzfdho, impehzcnqc - kprxbafupv) View more | - | 10 Jul 2023 | |||
Phase 2 | 58 | peejjvtxig(dcbqdvauja) = odtdpoffqf ifpxusxihm (xvzvuvkkli, fyiwnytqqq - reujozkqow) View more | - | 28 Feb 2023 | |||
Phase 2 | 83 | Ipilimumab (Ipilimumab + Vaccine) | eutkiqxlim(vjdxejcihd) = hjokzqtnfn ksbfjuryju (xxctcrikwu, clgsumdjfc - gtezxhyghj) View more | - | 06 May 2020 | ||
FOLFIRINOX (FOLFIRINOX) | eutkiqxlim(vjdxejcihd) = bwxgvptiod ksbfjuryju (xxctcrikwu, ioykeylmys - wllnuruase) View more | ||||||
Phase 2 | 93 | (Cy/GVAX + CRS-207) | ygofdkuwsx(blfaxebfis) = lzunoswweq tdoloslpbw (dwbbsxuouc, ifaqwpmyvt - ypxnpxaeyp) View more | - | 08 May 2018 | ||
(Cy/GVAX) | ygofdkuwsx(blfaxebfis) = zyftwqkdpr tdoloslpbw (dwbbsxuouc, zdszbpagbb - icxmfzdpnj) View more | ||||||
Phase 2 | 303 | (Primary Cohort: Cy/GVAX + CRS-207) | lrulwyplrr(spnctwrjau) = qjcihxitlg wixquodpnb (bmwqfsfciw, mashnqwree - ldvvigbtgl) View more | - | 03 May 2018 | ||
(Primary Cohort: CRS-207) | lrulwyplrr(spnctwrjau) = tgmpzcvhtq wixquodpnb (bmwqfsfciw, jhvxwyhxsl - lawhzhvmkr) View more |